Dom-Gene Tu

Dom-Gene Tu

Auto-generated profile, based on publicly available information

Dom-Gene Tu

Department of Nuclear Medicine, Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Chiayi City, Taiwan

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Stroke
Verified
Journal Article
Closed access
PHPi-Lien Hung
Pi-Lien Hung
CHChin-Wei Huang
Chin-Wei Huang
HHHsiu-Mei Huang
Hsiu-Mei Huang
DTDom-Gene Tu
Dom-Gene Tu
YCYing-Chao Chang
Ying-Chao Chang
Background and Purpose—: Low level of thyroid hormone is a strong independent risk factor for white matter (WM) injury, a major cause of cerebral palsy, in preterm infants. Thyroxin upregulates brain-derived neurotrophic factor during development. We hypothesized that thyroxin protected against preoligodendrocyte apoptosis and WM injury in the immature brain via upregulation of brain-derived neurotrophic factor. Methods—: Postpartum (P) day-7 male rat pups were exposed to hypoxic ischemia (HI) and intraperitoneally injected with thyroxin (T4; 0.2 mg/kg or 1 mg/kg) or normal saline immediately after HI at P9 and P11. WM damage was analyzed for myelin formation, axonal injury, astrogliosis, and preoligodendrocyte apoptosis. Neurotrophic factor expression was assessed by real-time polymerase chain reaction and immunohistochemistry. Neuromotor functions were measured using open-field locomotion (P11 and P21), inclined plane climbing (P11), and beam walking (P21). Intracerebroventricular injection of TrkB-Fc or systemic administration of 7,8-dihydroxyflavone was performed. Results—: On P11, the HI group had significantly lower blood T4 levels than the controls. The HI group showed ventriculomegaly and marked reduction of myelin basic protein immunoreactivities in the WM. T4 (1 mg/kg) treatment after HI markedly attenuated axonal injury, astrocytosis, and microgliosis, and increased preoligodendrocyte survival. In addition, T4 treatment significantly increased myelination and selectively upregulated brain-derived neurotrophic factor expression in the WM, and improved neuromotor deficits after HI. The protective effect of T4 on WM myelination and neuromotor performance after HI was significantly attenuated by TrkB-Fc. Systemic 7,8-dihydroxyflavone treatment ameliorated hypomyelination after HI injury. Conclusions—: T4 protects against WM injury at both pathological and functional levels via upregulation of brain-derived neurotrophic factor–TrkB signaling in the immature brain.

1 December 2016 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
DTDom-Gene Tu
Dom-Gene Tu
WLWei-Ting Lin
Wei-Ting Lin
CYCheng-Chia Yu
Cheng-Chia Yu
SLShiuan-Shinn Lee
Shiuan-Shinn Lee
CPChih-Yu Peng
Chih-Yu Peng
CYChuan-Hang Yu
Chuan-Hang Yu
Previously, we successfully identified oral cancer stem cells (OCSC) displaying enhanced stemness and tumorigenic potentials. In the study, we investigated the chemotherapeutic effect of the flavonoid luteolin, commonly found in fruits and vegetables, on targeting OCSC. Oralspheres was applied to isolate OCSC. aldehyde dehydrogenase 1 activity and CD44 positivity of OCSC with luteolin treatment were assessed by flow cytometry analysis. Radio-sensitivity of OCSC treated with luteolin was examined. Invasion and colony-forming assays were performed to assess oncogenicity in OCSC. The expression of interleukin-6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) was examined by enzyme-linked immunosorbent assay and western blot analysis. We showed that luteolin effectively inhibited the proliferation rate, self-renewal, aldehyde dehydrogenase 1 activity, and CD44 positivity of OCSC but did not cause significant cytotoxicity of normal epithelial cells. Moreover, luteolin restored radio-sensitivity in OCSC. Combined treatment with luteolin and radiation displayed synergistic effect on invasiveness and clonogenicity of OCSC. Mechanistically, treatment of luteolin resulted in inactivation of IL-6/STAT3 signaling. These results suggest that combined treatment of luteolin and radiation therapy can attenuate tumorigenicity of OCSC through IL-6/STAT3 signaling inactivation.

27 January 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
DTDom-Gene Tu
Dom-Gene Tu
Wen-Wei ChangWen-Wei Chang
Wen-Wei Chang
SLSong-Tao Lin
Song-Tao Lin
CKChun-Yu Kuo
Chun-Yu Kuo
YTYu-Tzu Tsao
Yu-Tzu Tsao
CLChe-Hsin Lee
Che-Hsin Lee
Salmonella inhibits tumor angiogenesis by downregulation of vascular endothelial growth factor

2 March 2016 in Oncology Letters
Verified
Journal Article
Open access
PDF file
DTDom-Gene Tu
Dom-Gene Tu
YYYun Yu
Yun Yu
CLChe-Hsin Lee
Che-Hsin Lee
YKYu-Liang Kuo
Yu-Liang Kuo
YLYin-Che Lu
Yin-Che Lu
Wen-Wei ChangWen-Wei Chang
Wen-Wei Chang
Hinokitiol, alternatively known as β-thujaplicin, is a tropolone-associated natural compound with antimicrobial, anti-inflammatory and antitumor activity. Breast cancer stem/progenitor cells (BCSCs) are a subpopulation of breast cancer cells associated with tumor initiation, chemoresistance and metastatic behavior, and may be enriched by mammosphere cultivation. Previous studies have demonstrated that BCSCs exhibit vasculogenic mimicry (VM) activity via the epidermal growth factor receptor (EGFR) signaling pathway. The present study investigated the anti-VM activity of hinokitiol in BCSCs. At a concentration below the half maximal inhibitory concentration, hinokitiol inhibited VM formation of mammosphere cells derived from two human breast cancer cell lines. Hinokitiol was additionally indicated to downregulate EGFR protein expression in mammosphere-forming BCSCs without affecting the expression of messenger RNA. The protein stability of EGFR in BCSCs was also decreased by hinokitiol. The EGFR protein expression and VM formation capability of hinokitiol-treated BCSCs were restored by co-treatment with MG132, a proteasome inhibitor. In conclusion, the present study indicated that hinokitiol may inhibit the VM activity of BCSCs through stimulating proteasome-mediated EGFR degradation. Hinokitiol may act as an anti-VM agent, and may be useful for the development of novel breast cancer therapeutic agents.

1 February 2005 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MCMing-Ho Chen
Ming-Ho Chen
JCJung-Chou Chen
Jung-Chou Chen
CTChin-Chuan Tsai
Chin-Chuan Tsai
WWWen-Chuang Wang
Wen-Chuang Wang
DCDe-Ching Chang
De-Ching Chang
HHHsiao-Yen Hsieh
Hsiao-Yen Hsieh

1 March 2020 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
BWBing-Sang Wong
Bing-Sang Wong
LCLing-Yen Chiu
Ling-Yen Chiu
DTDom-Gene Tu
Dom-Gene Tu
Gwo-Tarng SheuGwo-Tarng Sheu
Gwo-Tarng Sheu
TCTing-Tat Chan
Ting-Tat Chan
Purpose: Hypertension and cancer are frequently found comorbidity occurring in same individual. This study was intended to evaluate the anticancer effects of commonly used antihypertensive medications and chemotherapy on chemoresistant lung cancer cells. Methods: Calcium channel blockers (CCBs), including Verapamil, Diltiazem, and Nifedipine, either alone or combined with docetaxel (DOC) or vincristine (VCR) were used to treat A549 lung adenocarcinoma chemoresistant sublines. Cell viability was determined by MTT assay, and colony formation assay was used to demonstrate the long-term effect of CCBs on proliferation of the sublines. Apoptosis was evaluated by Annexin V assay and autophagy intensity was quantitated from acidic vesicular organelle formation. Pan-caspase inhibitor, shATG5 interference and chloroquine were applied to study the roles of Verapamil on apoptosis and autophagy, with related proteins verified by Western blot analysis. Results: Results show that 10 μM of Verapamil and Diltiazem, but not Nifedipine, differentially induce autophagy in DOC-resistant or VCR-resistant A549 cells, respectively. When CCBs are combined with DOC or VCR to treat the sublines, 10 μM of Verapamil induces autophagy more significantly than Diltiazem and Nifedipine, respectively, in DOC-resistant (54.91± 0.76, 18.03± 0.69, 7.05± 0.30) or VCR-resistant A549 (32.41± 1.04, 21.51± 0.63, 7.14± 0.24) cells. Inhibition of apoptosis by pan-caspase inhibitor partly reduced cell death indicates association of caspase-dependent cell death but with persistence of autophagy. Inhibition of autophagy by interfering ATG5 expression reduced c-PARP level and apoptotic cells suggest a pro-death role of autophagy. Chloroquine treatment enhanced autophagosome accumulation and cell death but with reduced c-PARP level suggests that mechanism of caspase-independent cell death also contributes to Verapamil/chemotherapy-induced anticancer effects. Conclusion: Verapamil combined with DOC or VCR induces chemoresistant lung cancer cells to death through autophagy burst and apoptosis more strongly than Diltiazem and Nifedipine. Administering Verapamil or Diltiazem individually with chemotherapy, but not Nifedipine, can be considered in lung cancer patients with hypertension.